New Drugs for Sickle Cell Disease: Small Benefit, Large Price
The FDA has approved two new drugs to treat sickle cell disease. They don’t do much, and they are prohibitively expensive. Sickle cell disease is a serious condition, an abnormality of hemoglobin that is inherited in an autosomal recessive pattern, where both parents have to pass on the defective gene. The red blood cells take